Dain Lee

Dain Lee

Auto-generated profile, based on publicly available information

Dain Lee

Department of Laboratory Medicine, Chonnam National University Medical School, Gwangju, Korea

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2020 in Mycobiology
Verified
Journal Article
Open access
Eun Jeong WonEun Jeong Won
Eun Jeong Won
MJMin Young Joo
Min Young Joo
DLDain Lee
Dain Lee
MKMi-Na Kim
Mi-Na Kim
YPYeon-Joon Park
Yeon-Joon Park
JSJong Hee Shin
Jong Hee Shin
We investigated the antifungal susceptibilities and the cyp51 mutant strains among Aspergillus fumigatus clinical isolates obtained from 10 university hospitals in Korea. Of the 84 isolates examined, two itraconazole-resistant isolates were found with no amino acid substitution in the cyp51A/cyp51B genes. However, 19 (23.2%) azole-susceptible isolates harbored amino acid substitutions: Nine isolates harbored one to five mutations in cyp51A with high polymorphism, and 11 isolates exhibited the same Q42L mutation in cyp51B. Overall, a low azole resistance rate and high frequency of cyp51A/cyp51B amino acid substitutions were observed in the azole-susceptible A. fumigatus isolates in Korea.

1 March 2021 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
JSJu Hyeon Shin
Ju Hyeon Shin
SKSoo Hyun Kim
Soo Hyun Kim
DLDain Lee
Dain Lee
SLSeung Yeob Lee
Seung Yeob Lee
SCSejong Chun
Sejong Chun
M.M.S.
M.S.
Ju Hyeon Shin, M.D., Soo Hyun Kim, M.D., Dain Lee, M.S., Seung Yeob Lee, M.D., Sejong Chun, M.D., Jun Hyung Lee, M.D., Eun Jeong Won, M.D., Hyun Jung Choi, M.D., Hyun Woo Choi, M.D., Seung Jung Kee, M.D., Myung Geun Shin, M.D., and Jong Hee Shin, M.D.. Ann Lab Med 2021;41:214-20. https://doi.org/10.3343/alm.2021.41.2.214

1 November 2021 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
SJSuhak Jeon
Suhak Jeon
JSJong Hee Shin
Jong Hee Shin
HLHa Jin Lim
Ha Jin Lim
MCMinji Choi
Minji Choi
SBSEUNGA BYUN
SEUNGA BYUN
M.M.S.
M.S.
Suhak Jeon, M.D., Jong Hee Shin, M.D., Ph.D., Ha Jin Lim, M.D., Min Ji Choi, Ph.D., Seung A Byun, M.S., Dain Lee, M.S., Seung Yeob Lee, M.D., Eun Jeong Won, M.D., Soo Hyun Kim, M.D., and Myung Geun Shin, M.D.. Ann Lab Med 2021;41:559-67. https://doi.org/10.3343/alm.2021.41.6.559

31 March 2020 in Korean Journal of Medical Mycology
Verified
Journal Article
Open access
JSJu Hyeon Shin
Ju Hyeon Shin
Eun Jeong WonEun Jeong Won
Eun Jeong Won
SKSoo Hyun Kim
Soo Hyun Kim
JSJong Hee Shin
Jong Hee Shin
DLDain Lee
Dain Lee
SJSeok Hoon Jeong
Seok Hoon Jeong
Background: Candidiasis control should include monitoring the epidemiology and resistance to various antifungal agents. In this study, the researchers investigated the Candida species recovered from clinical specimens at particular geographic areas or hospitals. Objective: The present study is geared toward the evaluation of antifungal drug usage at Korean hospitals in 2016. It is also essential that species distribution and antifungal susceptibilities of Candida isolates should be looked into to provide important data that can help devise therapeutic strategies to control the disease. Methods: Systemic antifungal agent usage over a one-year period was investigated at 10 Korean hospitals. Identification and antifungal susceptibility tests were performed on clinical isolates of the Candida species, which were collected over a three-month period. Results: The total antifungal usage in each hospital ranged from 7.7 to 158.9 defined daily doses (DDDs) per 1,000 patient days. Fluconazole was most commonly used (37.1%), followed by amphotericin B (30.6%), itraconazole (9.7%), echinocandins (8.8%), voriconazole (7.5%), and posaconazole (6.3%), respectively. Among 274 Candida isolates, C. albicans was the most frequently recovered (51.1%), followed by C. glabrata (15.7%), C. tropicalis (15.0%), and C. parapsilosis (13.5%), respectively. Through the application of either species-specific clinical breakpoints or epidemiological cutoff values to Candida isolates, the non-susceptibility rates to fluconazole, voriconazole, amphotericin B, and micafungin were found in 20.7%, 5.6%, 0%, and 0% of isolates, respectively. Conclusion: This nationwide multicenter study showed that total antifungal use varied considerably according to each hospital. Non-susceptibility to fluconazole should be further monitored, considering the drug's frequent use in Korea.